Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Citius Oncology, Inc., Common Stock

CTOR

NAQ

$1.15

-$0.03

(-2.54%)

Industry: Life Sciences Tools & Services Sector: Health Care

Analyst Forecast

Overview Returns Financials Ratios News FAQs

Price Chart

Key Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$82.29M

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

Volume

This is the total number of shares traded during the most recent trading day.

105.79K

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

52-week Range
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$0.85 L

$40.5 H

$1.15

About Citius Oncology, Inc., Common Stock

Citius Oncology, Inc. focuses on the development of novel targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adults with relapsed or refractory cutaneous T-cell lymphoma. The company is headquartered in New York, New York.Citius Oncology, Inc. operates as a subsidiary of Citius Pharmaceuticals, Inc. more

Industry: Life Sciences Tools & ServicesSector: Health Care

Returns

Time Frame	CTOR	Sector	S&P500
1-Week Return	-11.54%	0.49%	-0.42%
1-Month Return	4.55%	-3.1%	-2.2%
3-Month Return	18.56%	-8.59%	2.38%
6-Month Return	-97.16%	-4.57%	5.1%

Time Frame	CTOR	Sector	S&P500
1-Week Return	-99.83%	29.03%	-19.70%
1-Month Return	71.83%	-31.83%	-23.71%
3-Month Return	99.46%	-30.53%	10.01%
6-Month Return	-99.93%	-9.05%	10.61%

Financials

	Sep '22	Sep '23
Total Revenue	-	-	[{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true}]
Cost of Revenue	-	-	[{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true}]
Gross Profit	-	-	[{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true}]
Gross Margin	-	-	[{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true}]

Operating Expenses	4.86M	12.12M	[{"date":"2022-09-30","value":40.07,"profit":true},{"date":"2023-09-30","value":100,"profit":true}]
Operating Income	(4.86M)	(12.12M)	[{"date":"2022-09-30","value":-485659900,"profit":false},{"date":"2023-09-30","value":-1212124100,"profit":false}]
Total Non-Operating Income/Expense	-	-	[{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true}]
Pre-Tax Income	(4.86M)	(12.12M)	[{"date":"2022-09-30","value":-485659900,"profit":false},{"date":"2023-09-30","value":-1212124100,"profit":false}]
Income Taxes	-	-	[{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true}]
Income After Taxes	-	-	[{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true}]

Income From Continuous Operations	(5.43M)	(12.70M)	[{"date":"2022-09-30","value":-543259900,"profit":false},{"date":"2023-09-30","value":-1269724100,"profit":false}]
Income From Discontinued Operations	-	-	[{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true}]
Net Income	(5.43M)	(12.70M)	[{"date":"2022-09-30","value":-543259900,"profit":false},{"date":"2023-09-30","value":-1269724100,"profit":false}]

EPS (Diluted)	-	0.20	[{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":100,"profit":true}]

	Sep '22	Sep '23
Total Revenue	-	-	[{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true}]
Cost of Revenue	-	-	[{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true}]
Gross Profit	-	-	[{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true}]
Gross Margin	-	-	[{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true}]

Operating Expenses	-	149.58%	[{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":100,"profit":true}]
Operating Income	-	149.58%	[{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":100,"profit":true}]
Total Non-Operating Income/Expense	-	-	[{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true}]
Pre-Tax Income	-	149.58%	[{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":100,"profit":true}]
Income Taxes	-	-	[{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true}]
Income After Taxes	-	-	[{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true}]

Income From Continuous Operations	-	133.72%	[{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":100,"profit":true}]
Income From Discontinued Operations	-	-	[{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true}]
Net Income	-	133.72%	[{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":100,"profit":true}]

EPS (Diluted)	-	-	[{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true}]


Total Revenue	[]
Cost of Revenue	[]
Gross Profit	[]
Gross Margin	[]

Operating Expenses	[]
Operating Income	[]
Total Non-Operating Income/Expense	[]
Pre-Tax Income	[]
Income Taxes	[]
Income After Taxes	[]

Income From Continuous Operations	[]
Income From Discontinued Operations	[]
Net Income	[]

EPS (Diluted)	[]


Total Revenue	[]
Cost of Revenue	[]
Gross Profit	[]
Gross Margin	[]

Operating Expenses	[]
Operating Income	[]
Total Non-Operating Income/Expense	[]
Pre-Tax Income	[]
Income Taxes	[]
Income After Taxes	[]

Income From Continuous Operations	[]
Income From Discontinued Operations	[]
Net Income	[]

EPS (Diluted)	[]

	Sep '22	Sep '23
Total Assets
Current Assets	2.69M	7.73M	[{"date":"2022-09-30","value":34.78,"profit":true},{"date":"2023-09-30","value":100,"profit":true}]
Non-current Assets	40.00M	40.00M	[{"date":"2022-09-30","value":100,"profit":true},{"date":"2023-09-30","value":100,"profit":true}]
Total Assets	42.69M	47.73M	[{"date":"2022-09-30","value":89.43,"profit":true},{"date":"2023-09-30","value":100,"profit":true}]

Total Liabilities
Current Liabilities	5.85M	21.05M	[{"date":"2022-09-30","value":27.78,"profit":true},{"date":"2023-09-30","value":100,"profit":true}]
Non-current Liabilities	576.00K	1.15M	[{"date":"2022-09-30","value":50,"profit":true},{"date":"2023-09-30","value":100,"profit":true}]
Total Liabilities	6.42M	22.20M	[{"date":"2022-09-30","value":28.93,"profit":true},{"date":"2023-09-30","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	[{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true}]
Retained Earnings	(5.43M)	(18.13M)	[{"date":"2022-09-30","value":-543259900,"profit":false},{"date":"2023-09-30","value":-1812984000,"profit":false}]
Other Stockholders' Equity	-	-	[{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true}]
Total Shareholders' equity	36.27M	25.54M	[{"date":"2022-09-30","value":100,"profit":true},{"date":"2023-09-30","value":70.41,"profit":true}]

Total Liabilities & Shareholders Equity	42.69M	47.73M	[{"date":"2022-09-30","value":89.43,"profit":true},{"date":"2023-09-30","value":100,"profit":true}]

	Sep '22	Sep '23
Total Assets
Current Assets	-	187.52%	[{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":100,"profit":true}]
Non-current Assets	-	-	[{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true}]
Total Assets	-	11.82%	[{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":100,"profit":true}]

Total Liabilities
Current Liabilities	-	259.98%	[{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":100,"profit":true}]
Non-current Liabilities	-	100.00%	[{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":100,"profit":true}]
Total Liabilities	-	245.63%	[{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	[{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true}]
Retained Earnings	-	233.72%	[{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":100,"profit":true}]
Other Stockholders' Equity	-	-	[{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true}]
Total Shareholders' equity	-	(29.59%)	[{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":null,"profit":false}]

Total Liabilities & Shareholders Equity	-	11.82%	[{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":100,"profit":true}]


Total Assets
Current Assets	[]
Non-current Assets	[]
Total Assets	[]

Total Liabilities
Current Liabilities	[]
Non-current Liabilities	[]
Total Liabilities	[]

Total Shareholders' equity
Common Stock	[]
Retained Earnings	[]
Other Stockholders' Equity	[]
Total Shareholders' equity	[]

Total Liabilities & Shareholders Equity	[]


Total Assets
Current Assets	[]
Non-current Assets	[]
Total Assets	[]

Total Liabilities
Current Liabilities	[]
Non-current Liabilities	[]
Total Liabilities	[]

Total Shareholders' equity
Common Stock	[]
Retained Earnings	[]
Other Stockholders' Equity	[]
Total Shareholders' equity	[]

Total Liabilities & Shareholders Equity	[]

	Sep '22	Sep '23
Operating Activities
Net Operating Cash Flow	-	-	[{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true}]

Investing Activities
Net Investing Cash Flow	-	-	[{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	-	[{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true}]

Net Change in Cash	-	-	[{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true}]

Free Cash Flow
Free Cash Flow	-	-	[{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true}]

	Sep '22	Sep '23
Operating Activities
Net Operating Cash Flow	-	-	[{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true}]

Investing Activities
Net Investing Cash Flow	-	-	[{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	-	[{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true}]

Net Change in Cash	-	-	[{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true}]

Free Cash Flow
Free Cash Flow	-	-	[{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true}]

	Mar '24
Operating Activities
Net Operating Cash Flow	-	[{"date":"2024-03-31","value":"-","profit":true}]

Investing Activities
Net Investing Cash Flow	-	[{"date":"2024-03-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	[{"date":"2024-03-31","value":"-","profit":true}]

Net Change in Cash	-	[{"date":"2024-03-31","value":"-","profit":true}]

Free Cash Flow
Free Cash Flow	-	[{"date":"2024-03-31","value":"-","profit":true}]

	Mar '24
Operating Activities
Net Operating Cash Flow	-	[{"date":"2024-03-31","value":"-","profit":true}]

Investing Activities
Net Investing Cash Flow	-	[{"date":"2024-03-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	[{"date":"2024-03-31","value":"-","profit":true}]

Net Change in Cash	-	[{"date":"2024-03-31","value":"-","profit":true}]

Free Cash Flow
Free Cash Flow	-	[{"date":"2024-03-31","value":"-","profit":true}]

Ratios

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	CTOR
ROA (LTM)	0.00%
ROE (LTM)	0.00%

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	CTOR
Trailing PE	NM
Forward PE	NM
P/S (TTM)	0.00
P/B	4.55
EV/R	0.00
EV/Ebitda	NM

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is Citius Oncology, Inc. share price today?

Citius Oncology, Inc. (CTOR) share price today is $1.15

Can Indians buy Citius Oncology, Inc. shares?

Yes, Indians can buy shares of Citius Oncology, Inc. (CTOR) on Vested. To buy Citius Oncology, Inc. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in CTOR stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Citius Oncology, Inc. be purchased?

Yes, you can purchase fractional shares of Citius Oncology, Inc. (CTOR) via the Vested app. You can start investing in Citius Oncology, Inc. (CTOR) with a minimum investment of $1.

How to invest in Citius Oncology, Inc. shares from India?

You can invest in shares of Citius Oncology, Inc. (CTOR) via Vested in three simple steps:

Click on Sign Up or Invest in CTOR stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in Citius Oncology, Inc. shares

What is Citius Oncology, Inc. 52-week high and low stock price?

The 52-week high price of Citius Oncology, Inc. (CTOR) is $40.5. The 52-week low price of Citius Oncology, Inc. (CTOR) is $0.85.

What is Citius Oncology, Inc. price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Citius Oncology, Inc. (CTOR) is

What is Citius Oncology, Inc. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Citius Oncology, Inc. (CTOR) is 4.55

What is Citius Oncology, Inc. dividend yield?

The dividend yield of Citius Oncology, Inc. (CTOR) is 0.00%

What is the Market Cap of Citius Oncology, Inc.?

The market capitalization of Citius Oncology, Inc. (CTOR) is $82.29M

What is Citius Oncology, Inc.’s stock symbol?

The stock symbol (or ticker) of Citius Oncology, Inc. is CTOR